Bionime will be attending the EASD 2023!

At this event, we will showcase our Continuous Glucose Monitoring (CGM) on how to improve the quality of life for diabetes patients and enthusiastically share our vision in this field.

Bionime commits to pursue excellence by a corporate culture of 6 sigma DNA with a modern industrial 4.0-leveled production line which is to ensure the product quality and reliability. We make the CGM highly competitive since we have the product design and production automation in-house over 95%. And of course, there are over 380 patents filed so far and we’ve completed the FTO study. All these will contribute to make a reliable and competitive CGM for all diabetes patients.

We are looking forward to meeting you, sharing our vision, and exploring new opportunities to collaborate and innovate in the field of diabetes care together. See you at EASD 2023!